OraPharma, Inc. Release: New Study Confirms ARESTIN(R) + SRP More Effective Than SRP Alone In Eliminating Periodontal Pathogens

Published: Mar 08, 2006

A new study highlighting the antimicrobial effectiveness of ARESTINĀ® (minocycline hydrochloride) 1 mg Microspheres in the treatment of periodontal disease will be presented at the first joint annual session of the American Dental Education Association (ADEA) and the American Association for Dental Research (AADR), March 8-11, 2006 in Orlando, Florida.

Back to news